Adverse Reactions to Ginkgo biloba Medicinal Products Released in European Countries

被引:0
|
作者
Ammendolia, Ilaria [1 ,2 ]
Attard, Everaldo [3 ]
Mannucci, Carmen [4 ]
Esposito, Emanuela [1 ]
Calapai, Gioacchino [1 ]
Curro, Mariaconcetta [2 ]
Midiri, Paola [2 ]
Attard, Tamara [5 ]
Cardia, Luigi [6 ]
Calapai, Fabrizio [4 ]
机构
[1] Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Messina, Italy
[2] Univ Messina, Dept Clin & Expt Med, Messina, Italy
[3] Univ Malta, Inst Earth Syst, Div Rural Sci & Food Syst, Msida, Malta
[4] Univ Messina, Dept Biomed & Dent Sci & Morphol & Funct Imaging, Messina, Italy
[5] Univ Piemonte Orientale, Dept Food Chem, Biotechnol & Nutr Unit, Novara, Italy
[6] Univ Messina, Dept Human Pathol Adult & Childhood Gaetano Barres, Messina, Italy
关键词
adverse events; adverse reactions; disproportionality analysis; EudraVigilance; Ginkgo biloba; herbal medicinal products; pharmacovigilance; real-world data; reporting odds ratio; COMPLICATIONS;
D O I
10.1002/ptr.8475
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Patient Protection and Access to Innovative Medicinal Products in the European Union
    Markus Hartmann
    Florence Hartmann-Vareilles
    Drug information journal : DIJ / Drug Information Association, 2008, 42 (3): : 281 - 295
  • [32] Patient protection and access to innovative medicinal products in the European union
    Hartmann, Markus
    Hartmann-Vareilles, Florence
    DRUG INFORMATION JOURNAL, 2008, 42 (03): : 281 - 295
  • [33] Adverse drug reactions in children reported by European consumers from 2007 to 2011
    Aagaard, Lise
    Hansen, Ebba Holme
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2014, 36 (02) : 295 - 302
  • [34] Adverse drug reactions in children reported by European consumers from 2007 to 2011
    Lise Aagaard
    Ebba Holme Hansen
    International Journal of Clinical Pharmacy, 2014, 36 : 295 - 302
  • [35] Determination of toxic substances, pesticides and mycotoxins, in ginkgo biloba nutraceutical products by liquid chromatography Orbitrap-mass spectrometry
    Martinez-Dominguez, Gerardo
    Romero-Gonzalez, Roberto
    Garrido Frenich, Antonia
    MICROCHEMICAL JOURNAL, 2015, 118 : 124 - 130
  • [36] Determination of Chemical Composition and In Vitro Dissolution Profiles of Herbal Drug Products Containing Ginkgo biloba Available on the Brazilian Market
    Kratz, Jadel M.
    Terrazas, Claudia B.
    Motta, Monica J.
    Reginatto, Flavio H.
    Simoes, Claudia M. O.
    LATIN AMERICAN JOURNAL OF PHARMACY, 2008, 27 (05): : 674 - 680
  • [37] Adverse Drug Reaction Reporting by Patients in 12 European Countries
    Valinciute-Jankauskiene, Agne
    Kubiliene, Loreta
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (04) : 1 - 8
  • [38] The effect of Ginkgo biloba extract (EGb 761) on gliotic reactions in the hippocampal formation after unilateral entorhinal cortex lesions
    Dietrich, A
    Fülöp, ZL
    Chambers, MD
    Darrell, RS
    Stein, DG
    RESTORATIVE NEUROLOGY AND NEUROSCIENCE, 2000, 16 (02) : 87 - 96
  • [39] GINKGO BILOBA L. AND THE EFFECT OF ITS FERMENTED PRODUCTS ON PRODUCTION PHYSIOLOGY, BLOOD CHEMISTRY AND HISTOLOGY OF LIVESTOCK SPECIES: A REVIEW
    Ogbuewu, I. P.
    Mabelebele, M.
    Mbajiorgu, C. A.
    APPLIED ECOLOGY AND ENVIRONMENTAL RESEARCH, 2024, 22 (05): : 4563 - 4579
  • [40] Dosage strength is associated with medication persistence with Ginkgo biloba drug products: a cohort study of ambulatory drug claims data in Germany
    Czeche, Sittah
    Schuessel, Katrin
    Franzmann, Alexandra
    Burkart, Martin
    Schulz, Martin
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 13